May 20, 2021

M&A Sector Spotlight: US Healthcare Opportunities

Webinar On-Demand
In partnership with Mergermarket

M&A activity in Healthcare is on the move in 2021 and is proving to hold its course as we make our way through Q2.  With many new prospects on the horizon, we invite you to join us as we kick off a series of sector spotlights with our panel discussion "US Healthcare Opportunities." 

In this on-demand webinar presented with Mergermarket, industry experts will discuss current market trends and examine topics expected to dominate activity over the next few years, including:

  • What’s next for telehealth, remote pt monitoring, valuations and M&A
  • Deciding exits: SPACs vs IPO/direct listings, vs recaps
  • Pharma and the rush to gene therapies, genetic markers and diagnostics
  • CROs, CDMOs and the rush to scale

PANELISTS

Mark Francis

Managing Director, Head of Healthcare, Houlihan Lokey

Michael B. Kennedy II

Regional Vice President, Datasite

Newton Juhng

Managing Director, Capital One

Dane Hamilton

Healthcare Editor, Mergermarket & Dealreporter (moderator)

  • Americas Deal Drivers FY2020

    What impact has the pandemic had on M&A in the Americas? Download this comprehensive review of last year's activity to learn more.

Note: the above link will take you to the marketing hub on Mergermarket.com to access the event.

You may also like:

As the tide turns, what’s next? H2 2022 Market Outlook

Join Datasite as we unpack insights and trends from our global M&A report in partnership with PitchBook. In this live webinar, Datasite and PitchBook will host a panel of M&A leaders to unearth their H2 2022 market outlook, challenges, opportunities, and best practices amid a pivotal year.

Investment banker runs along a beach
M&A Deal Momentum: Influence of ESG on APAC Dealmaking

In the webinar, we will take a deep dive into to the fast-evolving and profoundly important area of ESG in APAC, analyzing the extent to which it is driving and transforming dealmaking in the region, which sectors are being impacted most, and what role technology is playing in diligence to execution.

Democratization of private equity

The emergence of retail investor/public investor money coming into private equity and several investment platforms are really starting to ‘democratize’ access to private equity. Is this connected with the growing number of IPOs that we are seeing for PE firms?